Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

BMRA
BIOMERICA INC
stock NASDAQ

At Close
Aug 29, 2025 3:59:30 PM EDT
3.12USD-1.266%(-0.04)77,308
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 29, 2025 8:33:30 AM EDT
3.25USD+2.848%(+0.09)745
After-hours
Aug 29, 2025 4:42:30 PM EDT
3.17USD+1.603%(+0.05)1,206
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 13, 2022
11:50AM EST  Biomerica's Return On Capital Employed Overview   Benzinga
08:19AM EST  -- Revenues up 239% over prior year fiscal second quarter -- Customer orders backlog of over $4.0 million at November 30, 2021 -- Walmart began in-store and online sales of Biomericas EZ Detect Colon Disease Test during fiscal second quarter -- InFoods IBS endpoint trial is complete, topline trial results expected by the end of January   GlobeNewswire Inc
Jan 12, 2022
04:36PM EST  Biomerica: Q2 Earnings Insights   Benzinga
04:29PM EST  Biomerica Q2 EPS $(0.09) Up From $(0.13) YoY, Sales $4.65M Up From $1.37M YoY   Benzinga
04:28PM EST  Biomerica Q2 EPS $(0.09) Up From $(0.13) YoY   Benzinga
Dec 16, 2021
08:20AM EST  Biomerica Sees Prelim. Q3 Sales $4.6M, Up 238% YoY   Benzinga
08:19AM EST  -- InFoods IBS Clinical Trial on Track for Completion in December with Topline Results Expected to be Announced in January, 2022.   GlobeNewswire Inc
Nov 19, 2021
08:21AM EST  Biomerica Forms Scientific Advisory Board For Colorectal Cancer Screening   Benzinga
08:19AM EST  Biomerica Forms Scientific Advisory Board for Colorectal Cancer   GlobeNewswire Inc
Nov 4, 2021
06:40AM EDT  Biomerica Reports Received Notice Of Allowance From Canadian Patent Office For Patent Covering Irritable Bowel Syndrome Food Sensitivity Testing & Treatment   Benzinga
06:39AM EDT  -- Studies show that 13-20% of Canadians suffer from IBS at any given time1. -- The lifetime risk for a Canadian to develop IBS is 30%1.   GlobeNewswire Inc
Oct 29, 2021
08:19AM EDT  -- Simple at-home breast exam device provides results within minutes -- Studies show increase in Breast Exam Sensitivity   GlobeNewswire Inc
Oct 19, 2021
07:34AM EDT  Recap: Biomerica Q1 Earnings   Benzinga
06:41AM EDT  Biomerica Highlights Walmart Has Begun In-Store Sales Of Co.'s EZ Detect Colorectal Screening Test   Benzinga
06:39AM EDT  -- Over 4,600 Walmart Stores to sell the EZ Detect product -- Simple 2 minute at-home test detects early warning sign of colorectal cancer   GlobeNewswire Inc
Oct 15, 2021
01:15PM EDT  Biomerica Tweets 'BUY NOW!' Referencing Colon Disease Test Being Sold At Walmart   Benzinga
07:44AM EDT  The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO   Benzinga
06:44AM EDT  Biomerica Q1 Net Loss $1.5 Mln Vs Loss $1.9 Mln Last Year   RTTNews
06:41AM EDT  Biomerica Q1 EPS $(0.12), Inline, Sales $1.26M Miss $2.05M Estimate   Benzinga
06:39AM EDT  -- Revenues up 10% over fiscal first quarter 2021, and 20% over fiscal fourth quarter 2021   GlobeNewswire Inc
Oct 14, 2021
06:12AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 06.00 A.M. EDT).   RTTNews
Oct 4, 2021
05:21AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.00 A.M. EDT).   RTTNews
Oct 1, 2021
02:51PM EDT  Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher   Benzinga
12:47PM EDT  Mid-Day Market Update: Dow Surges 300 Points; Omeros Shares Plummet   Benzinga
10:42AM EDT  Biomerica, Inc. (BMRA) shares are rising on Friday morning trade after the company announced an agreement with Walmart for the sale of EZ Detect colorectal disease screening test.   RTTNews
10:21AM EDT  Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Rises In September   Benzinga
08:26AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Friday, Oct. 1, 2021: AMZN, TSLA, BMRA, BITF, CEI   Benzinga
06:40AM EDT  Biomerica Reports Walmart Is Now Selling Its EZ Detect Colorectal Screening Test   Benzinga
06:39AM EDT  -- Simple 2 minute at-home test detects early warning sign of colorectal cancer   GlobeNewswire Inc
Aug 30, 2021
10:20AM EDT  Biomerica Late Friday Reported Q4 EPS $(0.12) Misses $(0.10) Estimate, Sales $1.05M Miss $2.63M Estimate   Benzinga
08:19AM EDT  Biomerica Says Expects Completion Of Patient Enrollment For InFoods Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week   Benzinga
08:19AM EDT  -- Final patients to compete this double blinded trial by end of October. -- Top-Line trial results expected by year end. -- The InFoods IBS Diagnostic-Guided Therapy is the first therapy of its kind for treating all forms of IBS. -- InFoods IBS product addresses the over $30 billion IBS market in the U.S. -- Approximately 40 million Americans suffer from IBS.   GlobeNewswire Inc
Aug 27, 2021
08:37PM EDT  Biomerica Reports Fiscal 2021 Year End Results   GlobeNewswire Inc
Aug 11, 2021
08:20AM EDT  Biomerica Announces Notice Of Allowance For Patent On Product Used To Diagnose And Treat Depression In Japan   Benzinga
08:19AM EDT  Biomerica Announces Notice of Allowance for Patent on Product used   GlobeNewswire Inc
Jun 24, 2021
08:19AM EDT  -- Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population   GlobeNewswire Inc
Jun 15, 2021
08:20AM EDT  Biomerica Receives Notice Of Allowance From Mexican Patent Office For Irritable Bowel Syndrome Food Sensitivity Testing & Treatment   Benzinga
08:19AM EDT  -- IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of around 16% [1](approximately 20 million patients) -- Broadens InFoods global patent coverage with recently allowed patents in Korea and Japan   GlobeNewswire Inc
Jun 4, 2021
08:00AM EDT  Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming investor conferences: the Truist Life Sciences Series and LD Micro Invitational XI event.   GlobeNewswire Inc
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
04:40PM EDT  MedTech Round Up: Update On Products By Biomerica, 908 Devices, Ekso Bionics, Hologic   Benzinga
08:22AM EDT  Biomerica Announces Its COVID-19 Antigen Rapid Test Cann Be Performed With a Nasal Swab   Benzinga
08:19AM EDT  -- Less invasive nasal swab taken from front opening of the nose is more comfortable for patients -- Test can be performed by doctors, school and company nurses, and medical assistants, in any location without specialized equipment   GlobeNewswire Inc
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
Apr 25, 2021
09:41AM EDT  BMRA: COVID-19 Test Contributes to More Than Doubling Of Revenue in 3Q FY21   Benzinga
Apr 23, 2021
07:28AM EDT  The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs   Benzinga
Apr 21, 2021
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Apr 15, 2021
10:43AM EDT  -- Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval -- Awarded two new patents for InFoods diagnostic guided therapy technology, including the first Japanese patent -- InFoods IBS diagnostic-guided therapy clinical trial expecting top line trial results by the third calendar quarter of 2021   GlobeNewswire Inc
10:43AM EDT  Biomerica Q3 Sales $3.62M, Up 208% YoY   Benzinga
Jan 15, 2021
09:29AM EST  Biomerica Q2 Sales $1.37M Down From $1.60M YoY   Benzinga
09:27AM EST  Biomerica Reports Fiscal 2021 Second Quarter Financial Results and   GlobeNewswire Inc
Jan 12, 2021
09:57AM EST  Shares of micro-cap company Biomerica Inc. (BMRA) gained 30% on Tuesday morning after the biomedical technology company said its new Covid-19 antigen test received CE mark.   RTTNews
08:20AM EST  Biomerica Receives CE Mark For Its COVID-19 Rapid Antigen Test   Benzinga
08:19AM EST  -- Biomerica receives first orders and plans to ship tests in coming weeks -- Clinical studies demonstrated an overall performance of 94.7% positive agreement (sensitivity) and 99.7% negative agreement (specificity) as compared to lab-based molecular PCR tests   GlobeNewswire Inc
Dec 9, 2020
08:22AM EST  -- Patient enrollment completion anticipated by the end of April 2021 -- InFoods Diagnostic-Guided Therapy is designed to address the $30 billion market for IBS treatment -- Therapy seeks to identify patient-specific foods that trigger IBS symptoms and suffering -- Approximately 45 million Americans suffer from IBS1   GlobeNewswire Inc
08:22AM EST  Biomerica's InFoods Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion Of Enrollment   Benzinga
Oct 19, 2020
12:33PM EDT  Aegis Capital Maintains Buy on Biomerica, Lowers Price Target to $11   Benzinga
Oct 16, 2020
02:31PM EDT  Mid-Afternoon Market Update: Dow Jumps 270 Points; Hertz Global Shares Spike Higher   Benzinga
12:04PM EDT  Mid-Day Market Update: Biomerica Drops After Q1 Results; CIT Group Shares Surge   Benzinga
10:18AM EDT  Mid-Morning Market Update: Markets Open Higher; Schlumberger Reports Mixed Q3 Results   Benzinga
09:53AM EDT  Shares of Biomerica Inc. (BMRA) are slipping 30% on Friday morning after the medical products maker reported third-quarter results.   RTTNews
09:28AM EDT  Biomerica Q1 EPS $(0.14), Sales $1.14M   Benzinga
09:27AM EDT  Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported financial results for the fiscal quarter ended August 31, 2020.   GlobeNewswire Inc
Sep 4, 2020
10:35AM EDT  Aegis Capital Maintains Buy on Biomerica, Raises Price Target to $13   Benzinga
Sep 1, 2020
08:19AM EDT  -- Fiscal fourth quarter revenues increase 133.7% over the prior year -- Fiscal 2020 revenues increase 28.7% over fiscal 2019 -- New InFoods patent granted for Singapore   GlobeNewswire Inc
Aug 31, 2020
08:38AM EDT  Biomerica Reveals Retirement Of Janet Moore As CFO; Names Steve Sloan As New CFO, Effective Sept 3   RTTNews
08:20AM EDT  Biomerica Announces Retirement Of Chief Financial Officer, Hiring Of New CFO And Appointment Of New Member To The Board Of Directors   Benzinga
08:20AM EDT  Biomerica CFO to Retire, Announces Steve Sloan CFO   Benzinga
08:19AM EDT  Biomerica Announces Retirement of Chief Financial Officer (CFO),   GlobeNewswire Inc
Aug 21, 2020
09:41AM EDT  Aegis Capital Initiates Coverage On Biomerica with Buy Rating, Announces Price Target of $10   Benzinga
Aug 12, 2020
08:24AM EDT  Biomerica Announces Notice Of Allowance For New U.S. Patent Application Covering Diagnostic Guided Therapy For Irritable Bowel Syndrome; Reports Co.'s Rapid Coronavirus Antibody Test Showed 100% Sensitivity, Specificity   Benzinga
08:19AM EDT  Biomerica Announces Notice of Allowance for New U.S. Patent   GlobeNewswire Inc
Jul 22, 2020
06:41AM EDT  Biomerica Announces Filing Of New Three Year Shelf Registration Statement; Co. Also Filing To Register 571,429 Shares Of Common Stock On Behalf Of Palm Global Master Small Cap Master Fund   Benzinga
06:39AM EDT  Biomerica Inc. (NASDAQ: BMRA) today announced that it has filed a new three year shelf registration statement on Form S-3 with the United States Securities and Exchange Commission (SEC) to replace its previous three year shelf registration statement, which was declared effective by the SEC in July 2017.   GlobeNewswire Inc
Jul 17, 2020
05:08AM EDT  64 Biggest Movers From Yesterday   Benzinga
Jul 16, 2020
02:51PM EDT  Why Biomerica's Stock Is Trading Higher Today   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC